Oryzon Genomics Market Cap

Oryzon Genomics has a market cap or net worth of $238.12 million as of April 29, 2025. Its market cap has increased by 90.06% in one year.

Market Cap

238.12M

Enterprise Value

250.18M

Revenue

7.62M

Ranking

n/a

PE Ratio

n/a

Stock Price

$3.03

Market Cap Chart

Since December 14, 2015, Oryzon Genomics's market cap has increased from 134.67M to 238.12M, an increase of 76.82%. That is a compound annual growth rate of 6.27%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2025	238.12M	153.88%
Dec 31, 2024	93.79M	-21.99%
Dec 29, 2023	120.23M	-15.47%
Dec 30, 2022	142.23M	-11.82%
Dec 30, 2021	161.30M	-37.25%
Dec 31, 2020	257.03M	81.12%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.63B
Nika Pharmaceuticals	1.02B
Veradigm	743.17M
Glass House Brands	483.81M
Elite Pharmaceuticals	443.14M
Northwest Biotherapeutics	402.45M
CytoDyn	288.39M
BioStem Technologies	244.71M

Market Cap Rankings